Brief: Oncopeptides' Pepaxti Has Been Granted Marketing Authorization In The UK
Nov 11 (Reuters) - Oncopeptides AB ONCO.ST :
* ONCOPEPTIDES' PEPAXTI HAS BEEN GRANTED MARKETING
AUTHORIZATION
IN THE UK
* MARKETING AUTHORIZATION IN UK IS BASED ON DATA FROM PHASE
2
HORIZON STUDY
Source text for Eikon: ID:nWkr3sgWWy
Further company coverage: ONCO.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy